Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
P/E ratio for Inogen, Inc. (INGN)
P/E ratio as of 2023: -1.24
According to Inogen, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.24. At the end of 2022 the company had a P/E ratio of -5.38.
P/E ratio history for Inogen, Inc. from 2011 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -1.24 |
| 2022 | -5.38 |
| 2021 | -120.74 |
| 2020 | -168.48 |
| 2019 | 71.17 |
| 2018 | 53.92 |
| 2017 | 117.28 |
| 2016 | 65.69 |
| 2015 | 67.13 |
| 2014 | 74.37 |
| 2013 | 10.75 |
| 2012 | 389.94 |
| 2011 | -109.85 |